# Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone

> **NCT05726903** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 35 (actual)

## Conditions studied

- Gender Dysphoria, Adolescent

## Interventions

- **DRUG:** Depo-subQ Provera Injectable Product

## Key facts

- **NCT ID:** NCT05726903
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-06
- **Primary completion:** 2023-11-17
- **Final completion:** 2023-11-17
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05726903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05726903, "Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05726903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*